137 related articles for article (PubMed ID: 34387166)
21. Strategies for overcoming tropical disease by ruthenium complexes with purine analog: Application against Leishmania spp. and Trypanosoma cruzi.
Fandzloch M; Arriaga JMM; Sánchez-Moreno M; Wojtczak A; Jezierska J; Sitkowski J; Wiśniewska J; Salas JM; Łakomska I
J Inorg Biochem; 2017 Nov; 176():144-155. PubMed ID: 28910663
[TBL] [Abstract][Full Text] [Related]
22. First dinuclear rhodium(II) complexes with triazolopyrimidines and the prospect of their potential biological use.
Fandzloch M; Augustyniak AW; Dobrzańska L; Jędrzejewski T; Sitkowski J; Wypij M; Golińska P
J Inorg Biochem; 2020 Sep; 210():111072. PubMed ID: 32563102
[TBL] [Abstract][Full Text] [Related]
23. Heterobimetallic nickel(II) and palladium(II) complexes derived from S-benzyl-N- (ferrocenyl)methylenedithiocarbazate: Trypanocidal activity and interaction with Trypanosoma cruzi Old Yellow Enzyme (TcOYE).
Carneiro ZA; Lima JC; Lopes CD; Gaspari APS; de Albuquerque S; Dinelli LR; Veloso-Silva LLW; Paganelli MO; Libardi SH; Oliveira CG; Deflon VM; Oliveira RJ; Borges JC; Maia PIS
Eur J Med Chem; 2019 Oct; 180():213-223. PubMed ID: 31306908
[TBL] [Abstract][Full Text] [Related]
24. Multi-target heteroleptic palladium bisphosphonate complexes.
Cipriani M; Rostán S; León I; Li ZH; Gancheff JS; Kemmerling U; Olea Azar C; Etcheverry S; Docampo R; Gambino D; Otero L
J Biol Inorg Chem; 2020 May; 25(3):509-519. PubMed ID: 32232584
[TBL] [Abstract][Full Text] [Related]
25. Experimental models in Chagas disease: a review of the methodologies applied for screening compounds against Trypanosoma cruzi.
Fonseca-Berzal C; Arán VJ; Escario JA; Gómez-Barrio A
Parasitol Res; 2018 Nov; 117(11):3367-3380. PubMed ID: 30232605
[TBL] [Abstract][Full Text] [Related]
26. New heteroleptic oxidovanadium(V) complexes: synthesis, characterization and biological evaluation as potential agents against Trypanosoma cruzi.
Scalese G; Machado I; Fontana C; Risi G; Salinas G; Pérez-Díaz L; Gambino D
J Biol Inorg Chem; 2018 Dec; 23(8):1265-1281. PubMed ID: 30194536
[TBL] [Abstract][Full Text] [Related]
27. In vitro anti-Trypanosoma cruzi activity of ternary copper(II) complexes and in vivo evaluation of the most promising complex.
Paixão DA; Lopes CD; Carneiro ZA; Sousa LM; de Oliveira LP; Lopes NP; Pivatto M; Chaves JDS; de Almeida MV; Ellena J; Moreira MB; Netto AVG; de Oliveira RJ; Guilardi S; de Albuquerque S; Guerra W
Biomed Pharmacother; 2019 Jan; 109():157-166. PubMed ID: 30396072
[TBL] [Abstract][Full Text] [Related]
28. Enzymatic synthesis of amlodipine amides and evaluation of their anti-
Elso OG; Bivona AE; Cenizo R; Malchiodi EL; García Liñares G
Org Biomol Chem; 2023 Feb; 21(7):1411-1421. PubMed ID: 36722938
[TBL] [Abstract][Full Text] [Related]
29. Cytotoxic malonate platinum(II) complexes with 1,2,4-triazolo[1,5-a]pyrimidine derivatives: structural characterization and mechanism of the suppression of tumor cell growth.
Łakomska I; Hoffmann K; Wojtczak A; Sitkowski J; Maj E; Wietrzyk J
J Inorg Biochem; 2014 Dec; 141():188-197. PubMed ID: 25277461
[TBL] [Abstract][Full Text] [Related]
30.
Mercaldi GF; Eufrásio AG; Ranzani AT; do Nascimento Faria J; Mota SGR; Fagundes M; Bruder M; Cordeiro AT
ACS Infect Dis; 2021 Aug; 7(8):2455-2471. PubMed ID: 34279922
[TBL] [Abstract][Full Text] [Related]
31. Targets and Patented Drugs for Chemotherapy of Chagas Disease in the Last 15 Years-Period.
Duschak VG
Recent Pat Antiinfect Drug Discov; 2016; 11(2):74-173. PubMed ID: 27784230
[TBL] [Abstract][Full Text] [Related]
32. New uses for old complexes: The very first report on the trypanocidal activity of symmetric trinuclear ruthenium complexes.
Possato B; Carneiro ZA; de Albuquerque S; Nikolaou S
J Inorg Biochem; 2017 Nov; 176():156-158. PubMed ID: 28915432
[TBL] [Abstract][Full Text] [Related]
33. Desing and synthesis of potent anti-Trypanosoma cruzi agents new thiazoles derivatives which induce apoptotic parasite death.
da Silva EB; Oliveira E Silva DA; Oliveira AR; da Silva Mendes CH; Dos Santos TA; da Silva AC; de Castro MC; Ferreira RS; Moreira DR; Cardoso MV; de Simone CA; Pereira VR; Leite AC
Eur J Med Chem; 2017 Apr; 130():39-50. PubMed ID: 28242550
[TBL] [Abstract][Full Text] [Related]
34. Structural Optimization and Biological Activity of Pyrazole Derivatives: Virtual Computational Analysis, Recovery Assay and 3D Culture Model as Potential Predictive Tools of Effectiveness against
Orlando LMR; Lechuga GC; da Silva Lara L; Ferreira BS; Pereira CN; Silva RC; Dos Santos MS; Pereira MCS
Molecules; 2021 Nov; 26(21):. PubMed ID: 34771151
[TBL] [Abstract][Full Text] [Related]
35. In vitro and in vivo antiparasitic activity of Physalis angulata L. concentrated ethanolic extract against Trypanosoma cruzi.
Meira CS; Guimarães ET; Dos Santos JA; Moreira DR; Nogueira RC; Tomassini TC; Ribeiro IM; de Souza CV; Ribeiro Dos Santos R; Soares MB
Phytomedicine; 2015 Oct; 22(11):969-74. PubMed ID: 26407938
[TBL] [Abstract][Full Text] [Related]
36. Pt
Gonçalves ACR; Carneiro ZA; Oliveira CG; Danuello A; Guerra W; Oliveira RJ; Ferreira FB; Veloso-Silva LLW; Batista FAH; Borges JC; de Albuquerque S; Deflon VM; Maia PIS
Eur J Med Chem; 2017 Dec; 141():615-631. PubMed ID: 29107428
[TBL] [Abstract][Full Text] [Related]
37. Activity on Trypanosoma cruzi, erythrocytes lysis and biologically relevant physicochemical properties of Pd(II) and Pt(II) complexes of thiosemicarbazones derived from 1-indanones.
Santos D; Parajón-Costa B; Rossi M; Caruso F; Benítez D; Varela J; Cerecetto H; González M; Gómez N; Caputto ME; Moglioni AG; Moltrasio GY; Finkielsztein LM; Gambino D
J Inorg Biochem; 2012 Dec; 117():270-6. PubMed ID: 23063173
[TBL] [Abstract][Full Text] [Related]
38. Examination of multiple Trypanosoma cruzi targets in a new drug discovery approach for Chagas disease.
Beltran-Hortelano I; Alcolea V; Font M; Pérez-Silanes S
Bioorg Med Chem; 2022 Mar; 58():116577. PubMed ID: 35189560
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and investigation of the trypanocidal potential of novel 1,2,3-triazole-selenide hybrids.
Chipoline IC; Brasil BFAB; Neto JSS; Valli M; Krogh R; Cenci AR; Teixeira KF; Zapp E; Brondani D; Ferreira LLG; Andricopulo AD; de Oliveira AS; Nascimento V
Eur J Med Chem; 2022 Dec; 243():114687. PubMed ID: 36057237
[TBL] [Abstract][Full Text] [Related]
40. Revisiting Pyrazolo[3,4-
Bouton J; Ferreira de Almeida Fiuza L; Cardoso Santos C; Mazzarella MA; Soeiro MNC; Maes L; Karalic I; Caljon G; Van Calenbergh S
J Med Chem; 2021 Apr; 64(7):4206-4238. PubMed ID: 33784107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
